| -1.62 / -2.44%|
The 13 analysts offering 12-month price forecasts for Cubist Pharmaceuticals Inc have a median target of 84.00, with a high estimate of 97.00 and a low estimate of 64.00. The median estimate represents a +29.79% increase from the last price of 64.72.
The current consensus among 17 polled investment analysts is to Buy stock in Cubist Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.